Literature DB >> 8011525

Intestinal iron absorption studies in mouse models of iron-overload.

K B Raja1, R J Simpson, T J Peters.   

Abstract

Three mouse strains have been evaluated as suitable models for investigations into the pathogenesis of iron-overload syndromes. Mice with hereditary heterozygous alpha-thalassaemia had moderately raised reticulocyte counts, but were not anaemic and showed little, if any, iron loading. In contrast, mice with homozygous beta-thalassaemia showed microcytic anaemia, reticulocytosis and splenomegaly. Iron-loading was marked, progressive with age and mainly confined to the spleen. Liver iron-loading increased until the age of 7-8 weeks, with no further increase over successive weeks. Although intestinal iron absorption was modestly increased due to enhanced mucosal uptake, the majority of the 'excess' liver and spleen iron could be accounted for by re-distribution of iron from the erythrocytic compartment. Homozygous hypotransferrinaemic mice, with approximately 1-2% of normal plasma transferrin levels, were markedly anaemic with hypochromic microcytic erythrocytes. Intestinal iron absorption increased 3-4-fold (predominantly due to changes in mucosal transfer), as compared to wild-type controls and heterozygotes, and was ascertained to be a major factor causing the marked hepatic iron overload. Heterozygous hypotransferrinamic mice, with over half normal plasma transferrin levels and a mild degree of hepatic iron loading, showed very similar characteristics to wild-type controls. Thus, of the three models, hpx/hpx mice showed the greatest enhancement in intestinal iron absorption and net iron-loading and provides a suitable animal model of spontaneous iron-overload. Comparison of iron absorption values between the models suggests that reticulocytes cannot account for the enhanced absorption seen in the hpx/hpx mice.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8011525     DOI: 10.1111/j.1365-2141.1994.tb03267.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

Review 1.  The use of hypotransferrinemic mice in studies of iron biology.

Authors:  Julia T Bu; Thomas B Bartnikas
Journal:  Biometals       Date:  2015-02-08       Impact factor: 2.949

2.  Decreasing TfR1 expression reverses anemia and hepcidin suppression in β-thalassemic mice.

Authors:  Huihui Li; Tenzin Choesang; Weili Bao; Huiyong Chen; Maria Feola; Daniel Garcia-Santos; Jie Li; Shuming Sun; Antonia Follenzi; Petra Pham; Jing Liu; Jinghua Zhang; Prem Ponka; Xiuli An; Narla Mohandas; Robert E Fleming; Stefano Rivella; Guiyuan Li; Yelena Z Ginzburg
Journal:  Blood       Date:  2017-02-01       Impact factor: 22.113

3.  Crosstalk between Iron Metabolism and Erythropoiesis.

Authors:  Huihui Li; Yelena Z Ginzburg
Journal:  Adv Hematol       Date:  2010-06-10

4.  Goat milk supplemented with folic acid protects cell biomolecules from oxidative stress-mediated damage after anaemia recovery in comparison with cow milk.

Authors:  Javier Díaz-Castro; Ana Sánchez-Alcover; Silvia Hijano; María J M Alférez; Teresa Nestares; Miguel Moreno; Margarita S Campos; Inmaculada López-Aliaga
Journal:  Eur J Nutr       Date:  2013-11-05       Impact factor: 5.614

5.  A mouse model for beta 0-thalassemia.

Authors:  B Yang; S Kirby; J Lewis; P J Detloff; N Maeda; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

6.  Fermented Goat Milk Consumption Enhances Brain Molecular Functions during Iron Deficiency Anemia Recovery.

Authors:  Jorge Moreno-Fernández; Inmaculada López-Aliaga; María García-Burgos; María J M Alférez; Javier Díaz-Castro
Journal:  Nutrients       Date:  2019-10-07       Impact factor: 5.717

7.  Role of Fermented Goat Milk on Liver Gene and Protein Profiles Related to Iron Metabolism during Anemia Recovery.

Authors:  Jorge Moreno-Fernandez; María J M Alférez; Inmaculada López-Aliaga; Javier Díaz-Castro
Journal:  Nutrients       Date:  2020-05-08       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.